MedPath

BioMS Technology Corp.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:10
Completed:0

Trial Phases

2 Phases

Phase 1:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 3
1 (33.3%)

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

Phase 3
Terminated
Conditions
Multiple Sclerosis, Secondary Progressive
Interventions
First Posted Date
2007-05-03
Last Posted Date
2009-08-13
Lead Sponsor
BioMS Technology Corp.
Target Recruit Count
510
Registration Number
NCT00468611

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.